Cargando…
Modeling and Simulation to Optimize the Design and Analysis of Confirmatory Trials, Characterize Risk–Benefit, and Support Label Claims
Autores principales: | Marshall, S F, Hemmings, R, Josephson, F, Karlsson, M O, Posch, M, Steimer, J-L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600757/ https://www.ncbi.nlm.nih.gov/pubmed/23835938 http://dx.doi.org/10.1038/psp.2013.4 |
Ejemplares similares
-
The Role of Modeling and Simulation in Development and Registration of Medicinal Products: Output From the EFPIA/EMA Modeling and Simulation Workshop
por: Manolis, E, et al.
Publicado: (2013) -
Distinguishing between Exploratory and Confirmatory Preclinical Research Will Improve Translation
por: Kimmelman, Jonathan, et al.
Publicado: (2014) -
Current Use and Developments Needed for Optimal Design in Pharmacometrics: A Study Performed Among DDMoRe's European Federation of Pharmaceutical Industries and Associations Members
por: Mentré, F, et al.
Publicado: (2013) -
Should benefit–risk assessment have its own drug “label”?
por: Braithwaite, R Scott
Publicado: (2011) -
Optimizing Interprofessional Simulation with Intentional Pre-Briefing and Debriefing
por: Penn, Jennifer, et al.
Publicado: (2023)